News
Filter by:

Kiadis to Acquire CytoSen Therapeutics, Inc.

April 17, 2019

Transaction creates leader in cell-based cancer immunotherapy, with complementary T-cell and Nk-cell platforms focused initially on hematopoietic stem cell transplants (HSCT) CytoSen’s lead Nk-cell therapy candidate, CSDTO02-NK,…

Learn More